Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
AMI 25
Known as:
AMI-25
, AMI25
National Institutes of Health
Create Alert
Related topics
Related topics
1 relation
Broader (1)
ferumoxides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
1998
Review
1998
Hepatic MRI with SPIO: detection and characterization of focal liver lesions
P. Reimer
,
B. Tombach
European Radiology
1998
Corpus ID: 21880897
Abstract. A variety of parenterally administered iron oxides have been developed for contrast-enhanced MRI of the liver. Two…
Expand
Highly Cited
1996
Highly Cited
1996
Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
T. Vogl
,
R. Hammerstingl
,
+9 authors
R. Félix
Radiology
1996
Corpus ID: 31657669
PURPOSE To assess AMI-25- versus gadolinium-enhanced magnetic resonance (MR) imaging in the differential diagnosis of liver…
Expand
Highly Cited
1995
Highly Cited
1995
Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
C. W. Jung
Magnetic resonance imaging
1995
Corpus ID: 42576183
The surface properties of the active ingredients in AMI colloidal, superparamagnetic iron oxide magnetic resonance (MR) contrast…
Expand
Highly Cited
1994
Highly Cited
1994
Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25.
A. Denys
,
L. Arrivé
,
+4 authors
Y. Menu
Radiology
1994
Corpus ID: 21103422
PURPOSE To evaluate the ability of magnetic resonance (MR) imaging enhanced with AMI-25 to depict and characterize hepatic tumors…
Expand
Highly Cited
1990
Highly Cited
1990
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
R. Weissleder
,
G. Elizondo
,
J. Wittenberg
,
C. Rabito
,
H. Bengele
,
L. Josephson
Radiology
1990
Corpus ID: 2853737
An ultrasmall superparamagnetic iron oxide (USPIO) preparation was developed that is small enough to migrate across the capillary…
Expand
Highly Cited
1990
Highly Cited
1990
Assessment of a superparamagnetic iron oxide (ami‐25) as a brain contrast agent
T. A. Kent
,
M. Quast
,
B. J. Kaplan
,
R. S. Lifsey
,
H. Eisenberg
Magnetic resonance in medicine
1990
Corpus ID: 35263905
We have applied a superparamagnetic iron oxide formulation (AMI‐25, Advanced Magnetics, Inc., Cambridge, MA) to image the…
Expand
Highly Cited
1990
Highly Cited
1990
Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors.
P. Hahn
,
D. Stark
,
R. Weissleder
,
G. Elizondo
,
S. Saini
,
J. Ferrucci
Radiology
1990
Corpus ID: 35988404
Previous studies of AMI-25, a particulate iron oxide magnetic resonance contrast agent, imaged liver tumors 1 or more hours after…
Expand
Highly Cited
1989
Highly Cited
1989
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
R. Weissleder
,
D. Stark
,
+5 authors
J. Lewis
AJR. American journal of roentgenology
1989
Corpus ID: 37829799
The pharmacokinetics (distribution, metabolism, bioavailability, excretion) and toxicity (acute and subacute toxicity…
Expand
Highly Cited
1989
Highly Cited
1989
The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide.
R. Weissleder
,
G. Elizondo
,
+6 authors
J. Ferrucci
AJR. American journal of roentgenology
1989
Corpus ID: 38822653
This study was designed to evaluate superparamagnetic iron oxide (AMI-25) as a contrast agent for MR to distinguish normal…
Expand
Highly Cited
1988
Highly Cited
1988
Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging.
R. Weissleder
,
P. Hahn
,
+5 authors
J. Ferrucci
Radiology
1988
Corpus ID: 38352593
Superparamagnetic iron oxide (AMI-25), a reticuloendothelial cell-specific contrast agent for magnetic resonance (MR) imaging…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE